Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?-Reference-Cited by-同舟云学术

Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?

Published:2017-04-10 Issue:25 Volume:8 Page:41044-41063
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Mohamed Amira¹²,Romano David¹,Saveanu Alexandru¹²,Roche Catherine²,Albertelli Manuela³,Barbieri Federica³,Brue Thierry¹⁴,Niccoli Patricia⁵,Delpero Jean-Robert⁶,Garcia Stephane⁷,Ferone Diego³,Florio Tullio³,Moutardier Vincent⁸,Poizat Flora⁹,Barlier Anne¹²,Gerard Corinne¹

Affiliation:

1. Aix Marseille Univ, CNRS, CRN2M, Marseille, France

2. APHM, Conception Hospital, Molecular Biology Laboratory, Marseille, France

3. Department of Internal Medicine and Center of Excellence for Biomedical Research, University of Genova, Genova, Italy

4. APHM, Conception Hospital, Endocrinology Department, Marseille, France

5. Paoli Calmettes Cancer Institute, Oncology Department, IPC CoE-ENETS, Marseille, France

6. Paoli Calmettes Cancer Institute, Surgery Department, IPC CoE-ENETS, Marseille, France

7. APHM, North Hospital, Pathology Laboratory, Marseille, France

8. APHM, North Hospital, Surgery Department, Marseille, France

9. Paoli Calmettes Cancer Institute, Biopathology Department, IPC CoE-ENETS, Marseille, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Neuropeptides in Sarcomas;Neurochemical Journal;2023-12

2. Three Dimensional Models of Endocrine Organs and Target Tissues Regulated by the Endocrine System;Cancers;2023-09-17

3. Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions;Cancers;2023-07-25

4. Reciprocal Interactions between Fibroblast and Pancreatic Neuroendocrine Tumor Cells: Putative Impact of the Tumor Microenvironment;Cancers;2022-07-18

5. A Real-world Multicenter Prospective Study of Everolimus in Pancreatic Neuroendocrine Tumors: The ‘PROTOR’ Study;Anticancer Research;2022-03-28